Pulmonary arterial capillary bed

The pulmonary arterial capillary bed is a complex microvascular network located at the terminus of the pulmonary arterial tree, where it facilitates the exchange of oxygen and carbon dioxide across the alveolar-capillary membrane (StatPearls, 2023). Functionally, it serves as a low-resistance circuit that accommodates the entire cardiac output, maintaining hemodynamic stability and efficient gas transport (NIH, 2022). In diseases such as pulmonary arterial hypertension (PAH) and pulmonary capillary hemangiomatosis, the bed undergoes pathological remodeling characterized by endothelial dysfunction, smooth muscle proliferation, and vessel obliteration (Circulation Research, 2020). Although it is an anatomical structure rather than a single molecular entity, it serves as the physiological environment for several high-value molecular targets, including endothelin receptors (ET-A/ET-B), phosphodiesterase-5 (PDE5), and soluble guanylate cyclase (sGC) (PubMed, 2021). Therapeutic agents like bosentan, sildenafil, and riociguat interact with these specific molecules within the capillary bed to decrease vascular resistance and improve pulmonary hemodynamics (FDA, 2023). Monitoring the integrity and function of this bed via hemodynamics and imaging is crucial for assessing patient response to therapy in pulmonary vascular diseases (Lancet Respiratory Medicine, 2022).

Other names

Pulmonary capillariesAlveolar capillary networkPulmonary microvasculatureLung capillary bedAlveolar-capillary unit

Drugs acting within the pulmonary arterial capillary bed primarily induce vasodilation and inhibit vascular remodeling by modulating the nitric oxide pathway, antagonizing endothelin receptors, or activating prostacyclin pathways.